415 CAPITAL Overview
415 Capital is a specialist venture capital firm dedicated to investing in breakthrough and life-saving medical innovations. With over 25 years of experience, the firm provides exceptional entrepreneurs with capital, expertise, and market access, focusing on large unmet patient needs in chronic diseases, particularly cardiovascular and neurovascular disorders.
Is 415 CAPITAL the right investor for your startup? Browse their investment focus, stage preferences, and geographic scope to see how well they align with your fundraising goals. Your full match score with 415 CAPITAL, along with a list of other relevant VCs, is available on Hopohopo.io.
415 CAPITAL
Investment focus
Product type
- Hardware
- Software-enabled hardware
Industries / verticals
- MedTech & Devices
Investment role
Lead and follow
Stages
Series A, Series B or later
First ticket size
€5,000,000 - €15,000,000
Contact information
Senior Venture Partner
Michael Braun
Investment Intern
Julia Hoffmeister
Partner
Ruben Osnabrugge
Co-Founder
David Thompson
How to approach funds like 415 CAPITAL
When approaching 415 Capital, founders should highlight robust clinical validation and a clear regulatory pathway for their medical innovation, especially if addressing significant gaps in chronic disease care. Demonstrate a deep understanding of the patient journey and the commercial potential within cardiovascular or neurovascular markets. Articulate how your team’s expertise and network can accelerate adoption and de-risk development, aligning with 415 Capital’s hands-on, partnership-driven investment style.
Find the best-fitting investors for your startup
Stop wasting weeks searching for the right investors. Upload your deck and get matched with investors who actually fit your startup — so you can focus on building, not chasing.
